AHIX yields 44444.44% · PFE yields 6.13%● Live data
📍 AHIX pulled ahead of the other in Year 1
Combined, AHIX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AHIX + PFE for your $10,000?
Aluf Holdings, Inc., through its subsidiaries, develops proprietary software, software algorithms, and hardware for testing and data mining of computer hard drives, memory, and magnetics, as well as semiconductor and nanotechnology- based device components. It builds advanced test solutions for engineering and manufacturing sectors to verify devices made correctly; reliability tests to predict when the device will fail during usage; and characterization tests to verify the manufacturing operation in building the device. Its product lines include Predictive, Demonstrated, and Quantitative (PDQ) - Wafer Level Reliability (WLR), a wafer level reliability test software package; the ASUR SDR software suite that provides an environment in which users can test semiconductor wafers by using the JEDEC compliant PDQ-WLR algorithm library; and ASUR PDR, which provides an immediate view of stresses and device behaviors through the use of its real-time plotting tool. The company also provides shipping and coordination services for retail and wholesale, electronics, and manufacturing companies worldwide; and operates cloud based tracking and e-logistics. In addition, it manufactures and processes CBD distillate, a THC-free, purified form of CBD. The company was formerly known as COREwafer Industries, Inc. and changed its name to Aluf Holdings, Inc. in August 2015. Aluf Holdings, Inc. was incorporated in 1977 and is headquartered in Hollywood, Florida.
Full AHIX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.